Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atip Lawanprasert

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
ACS Applied Materials & Interfaces|February 1, 2021
Tuning the Interfacial Properties of Fluorous Colloids Toward Ultrasound Programmable BioactivityAtip Lawanprasert, Alda Chau, Janna N Sloand, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 7, 2018
Bioresponsive peptide-polysaccharide nanogels - A versatile delivery system to augment the utility of bioactive cargoAndrew W Simonson, Atip Lawanprasert, Tyler D P Goralski, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 15, 2023
Real-Time, In Situ Imaging of Macrophages via Phase-Change Peptide NanoemulsionsInhye Kim, Jacob C Elliott, Atip Lawanprasert, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
CRISPR-Cas13d-Mediated Targeting of a Context-Specific Essential Gene Enables Selective Elimination of Uveal MelanomaDaniel Stauber, Lucas Sosnick, Yitong Ma, et al.
Nature Communications|December 31, 2024
Heat stable and intrinsically sterile liquid protein formulationsAtip Lawanprasert, Harminder Singh, Sopida Pimcharoen, et al.
ACS Applied Materials & Interfaces|July 16, 2024
Decoupling Fluorous Protein Coatings Yield Heat-Stable and Intrinsically Sterile BioformulationsHarminder Singh, Atip Lawanprasert, Utkarsh, et al.
Molecular Therapy. Oncology|April 17, 2026
A CRISPR-Cas13d cancer therapeutic enables selective elimination of uveal melanomaDaniel Stauber, Lucas Sosnick, Yitong Ma, et al.
Biomacromolecules|January 26, 2022
Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen PresentationAtip Lawanprasert, Andrew W Simonson, Sarah E Sumner, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 3, 2022
Heparin-Peptide Nanogranules for Thrombosis-Actuated AnticoagulationAtip Lawanprasert, Sopida Pimcharoen, Sarah E Sumner, et al.
Biomaterials|April 29, 2021
Extracellular matrix-inspired inhalable aerogels for rapid clearance of pulmonary tuberculosisAndrew W Simonson, Todd M Umstead, Atip Lawanprasert, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
ACS Applied Materials & Interfaces|February 1, 2021
Tuning the Interfacial Properties of Fluorous Colloids Toward Ultrasound Programmable BioactivityAtip Lawanprasert, Alda Chau, Janna N Sloand, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 7, 2018
Bioresponsive peptide-polysaccharide nanogels - A versatile delivery system to augment the utility of bioactive cargoAndrew W Simonson, Atip Lawanprasert, Tyler D P Goralski, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 15, 2023
Real-Time, In Situ Imaging of Macrophages via Phase-Change Peptide NanoemulsionsInhye Kim, Jacob C Elliott, Atip Lawanprasert, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
CRISPR-Cas13d-Mediated Targeting of a Context-Specific Essential Gene Enables Selective Elimination of Uveal MelanomaDaniel Stauber, Lucas Sosnick, Yitong Ma, et al.
Nature Communications|December 31, 2024
Heat stable and intrinsically sterile liquid protein formulationsAtip Lawanprasert, Harminder Singh, Sopida Pimcharoen, et al.
ACS Applied Materials & Interfaces|July 16, 2024
Decoupling Fluorous Protein Coatings Yield Heat-Stable and Intrinsically Sterile BioformulationsHarminder Singh, Atip Lawanprasert, Utkarsh, et al.
Molecular Therapy. Oncology|April 17, 2026
A CRISPR-Cas13d cancer therapeutic enables selective elimination of uveal melanomaDaniel Stauber, Lucas Sosnick, Yitong Ma, et al.
Biomacromolecules|January 26, 2022
Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen PresentationAtip Lawanprasert, Andrew W Simonson, Sarah E Sumner, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 3, 2022
Heparin-Peptide Nanogranules for Thrombosis-Actuated AnticoagulationAtip Lawanprasert, Sopida Pimcharoen, Sarah E Sumner, et al.
Biomaterials|April 29, 2021
Extracellular matrix-inspired inhalable aerogels for rapid clearance of pulmonary tuberculosisAndrew W Simonson, Todd M Umstead, Atip Lawanprasert, et al.
Pageof 2